Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Geriatrics Reports
Published in: Current Geriatrics Reports 3/2016

01-09-2016 | Hematology and Oncology (TM Wildes, Section Editor)

Assessment of physical function in geriatric oncology based on International Classification of Functioning, Disability and Health (ICF) framework

Authors: Venkadesan Rajendran, Deepa Jeevanantham

Published in: Current Geriatrics Reports | Issue 3/2016

Login to get access

Abstract

Older patients with cancer may have multiple physical impairments, such as limitation in range of motion, muscle weakness, lack of coordination, and balance and gait dysfunction. A patient’s physical function may be further limited by pain, fatigue, depression, and shortness of breath that hasten the deconditioning process and affect their overall quality of life. Understanding the common impairments in cancer would help the therapist to assess and treat them effectively; thus, this article aims to provide an overview of functional limitations associated with cancer and its treatments and the use of the International Classification of Functioning, Disability and Health as a keystone for selection of appropriate outcome measures to assess physical function that would help the physiotherapist to design an effective treatment for older patients with cancer.
Literature
1.
2.
Rowland JH. Cancer survivorship: rethinking the cancer control continuum. Semin Oncol Nurs. 2008;24:145–52.PubMedCrossRef
3.
4.
National Cancer Institute of Canada: Canadian Cancer Statistics 2000. Toronto, Canada, National Cancer Institute of Canada 2000.
5.
6.
Kayl AE, Meyers CA. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol. 2006;18:24–8.PubMedCrossRef
7.
Kurt G, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist. 2000;5:353–60.CrossRef
8.
Perez EA, Suman VJ, Davidson NE, et al. Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol. 2004;22:3700–4.PubMedCrossRef
9.
Freedman RJ, Aziz N, Albanes D, et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab. 2004;89:2248–53.PubMedCrossRef
10.
Stevinson C, Lawlor DA, Fox KR. Exercise interventions for cancer patients: systematic review of controlled clinical trials. Cancer Causes Control. 2004;15:1035–56.PubMedCrossRef
11.
Knols R, Aaronson NA, Uebelhart D, et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol. 2005;23:3830–42.PubMedCrossRef
12.
Galva˜o D, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005;23:899–909.CrossRef
13.
Courneya KS, Katzmarzyk PT, et al. Physical activity and obesity in Canadian cancer survivors: population-based estimates from the 2005 Canadian Community Health Survey. Cancer. 2008;112(11):2475–82.PubMedCrossRef
14.
Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28(3):753–65.PubMedCrossRef
15.
Brown CJ, Friedkin RJ, Inouye SK. Prevalence and outcomes of low mobility in hospitalized older patients. J Am Geriatr Soc. 2004;52:1263–70.PubMedCrossRef
16.
17.
Narain P, Rubenstein LZ, Wieland GD, et al. Predictors of immediate and 6-month outcomes in hospitalized elderly patients. J Am Geriatr Soc. 1988;36:775–83.PubMedCrossRef
18.
Hirsch CH, Sommers L, Olsen A, et al. The natural history of functional morbidity in hospitalized older patients. J Am Geriatr Soc. 1990;38:1296–303.PubMedCrossRef
19.
Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Ustün TB. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil. 2002;24(5):281–2.PubMedCrossRef
20.
Ahles T, Saykin A. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer. 2002;3:S84–90.PubMedCrossRef
21.
Barton D, Loprinizi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. Clin Breast Cancer. 2002;3:S121–7.PubMedCrossRef
22.
Castellon S, Ganz P, Bower J, et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol. 2004;26:955–69.PubMedCrossRef
23.
Dam FV, Schagen S, Muller M, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Nat Cancer Inst. 1998;90:210–8.PubMedCrossRef
24.
Freeman J, Broshek D. Assessing cognitive dysfunction in breast cancer: what are the tools? Clin Breast Cancer Suppl. 2002;3:91–9.CrossRef
25.
Olin J. Cognitive function after systemic therapy for breast cancer. Oncology. 2001;15:613–8.PubMed
26.
Rugo H, Ahles T. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Semin Oncol. 2003;30:749–62.PubMedCrossRef
27.
Schagen S, Van Dam F, Muller M, et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85:640–50.PubMedCrossRef
28.
Stewart A, Bielajew C, Collins B, et al. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20:76–89.PubMedCrossRef
29.
Tchen N, Juffs H, Downie F, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 2003;21:4175–83.PubMedCrossRef
30.
Wefel J, Lenxi R, Theriault R, et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292–9.PubMedCrossRef
31.
Wieneke M, Dienst E. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology. 1995;4:61–6.CrossRef
32.
Verstappen CCP, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer. Drugs. 2003;63:1549–63.PubMedCrossRef
33.
Chaudhry V, Rowinsky EK, Sartorius SE, et al. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol. 1994;35:304–11.PubMedCrossRef
34.
Chaudhry V, Chaudhry M, Crawford TO, et al. Toxic neuropathy in patients with pre-existing neuropathy. Neurology. 2003;60:337–40.PubMedCrossRef
35.
Cavaletti G, Bogliun G, Marzorati L, et al. Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale. Neurology. 2003;61:1297–300.PubMedCrossRef
36.
Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin. 2002;52:72–91.PubMedCrossRef
37.
Holley S. A look at the problem of falls among people with cancer. Clin J Oncol Nurs. 2002;6:193–7.PubMedCrossRef
38.
39.
Floyd J, Nguyen D, Lobins R, et al. Cardiotoxicity of cancer therapy. J Clin Oncol. 2005;23:7685–96.PubMedCrossRef
40.
Harris E, Correa C, Hwang W, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast conservation treatment. J Clin Oncol. 2006;24:4100–6.PubMedCrossRef
41.
42.
Gilchrist LS, Galantino ML, Wampler M, Marchese VG, Morris GS. Ness KK.A framework for assessment in oncology rehabilitation. Phys Ther. 2009;89(3):286–306.PubMedPubMedCentralCrossRef
43.•
Joseph A, Daniel M. Early mobilization in the intensive care unit: a systematic review. Cardiopulm Phys Ther J. 2012;23(1):5–13. Reviews the red flags and step by step procedures for safe mobilization.
44.
Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O’Reilly MG, Winters WL, Gibbons RJ,Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee to Update the 1997 Exercise Testing Guidelines. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).J Am Coll Cardiol. 2002; 40(8):1531–40.
45.
Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104(14):1694–740.PubMedCrossRef
46.
Perme C, Chandrashekar R. Early mobility and walking program for patients in intensive care units: creating a standard of care. Am J Crit Care. 2009;18(3):212–21.PubMedCrossRef
47.
Buatois S, Miljkovic D, Manckoundia P, et al. Five times sit to stand test is a predictor of recurrent falls in healthy community‐living subjects aged 65 and older. J Am Geriatr Soc. 2008;56(8):1575–7.PubMedCrossRef
48.••
Campbell KL, Pusic AL, Zucker DS, et al. A prospective model of care for breast cancer rehabilitation: function. Cancer. 2012;15(118):2300–11. Reviews a prospective model of care for beast cancer rehabilitation.CrossRef
49.
Bohannon RW. Reference values for the five‐repetition sit‐to‐stand test: a descriptive meta analysis of data from elders. Percept Mot Skills. 2006;103(1):215–22.PubMedCrossRef
50.
Megens AM, Harris SR, Kim-Sing C, McKenzie DC. Measurement of upper extremity volume in women after axillary dissection for breast cancer. Arch Phys Med Rehabil. 2001;82(12):1639–44.PubMedCrossRef
51.
Mondry TE, Riffenburgh RH, Johnstone PA. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J. 2004;10(1):42–8.PubMedCrossRef
52.
Bicego D, Brown K, Ruddick M, et al. Exercise for women with or at risk for breast cancer-related lymphedema. Phys Ther. 2006;86(10):1398–405.PubMedCrossRef
53.
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRef
54.
Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol. 2003;21(19):3557–8.PubMedCrossRef
55.
Richardson LA, Jones GW. A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol. 2009;16(1):55.PubMedPubMedCentral
56.
DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
57.
Costello E, Elrod C, Tepper S. Clinical decision making in the acute care environment: a survey of practicing clinicians. Journal of acute care physical therapy. 2011;2(92):46–54.CrossRef
58.
59.
Rybak LP, Mukherjea D, Jajoo S, Ramkumar V. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med. 2009;219(3):177–86.PubMedPubMedCentralCrossRef
60.
Enticott JC, O’leary SJ, Briggs RJ. Effects of vestibulo-ocular reflex exercises on vestibular compensation after vestibular Schwannoma surgery. Otol Neurotol. 2005;26(2):265–9.PubMedCrossRef
61.
McGinnis PQ, Hack LM, Nixon-Cave K, Michlovitz SL. Factors that influence the clinical decision making of physical therapists in choosing a balance assessment approach. Phys Ther. 2009;89:233–47.PubMedCrossRef
62.
Bylow K, Dale W, Mustian K, et al. Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology. 2008;72(2):422–7.PubMedPubMedCentralCrossRef
63.
Scott V, Votova K, Scanlan A, Close J. Multifactorial and functional mobility assessment tools for fall risk among older adults in community, home-support, long-term and acute care settings. Age Ageing. 2007;36(2):130–9.PubMedCrossRef
64.
Berg KO, Maki BE, Williams JI, Holliday PJ, Wood-Dauphinee SL. Clinical and laboratory measures of postural balance in an elderly population. Arch Phys Med Rehabil. 1992;73(11):1073–80.PubMed
65.
Berg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health. 1992;83(2):S7–11.PubMed
66.
Elliott J. The clinical use of the berg balance scale [abstract]. Physiotherapy. 1997; 83:363.
67.
Gilchrist LS, Galantino ML, Wampler M, Marchese VG, Morris GS, Ness KK. A framework for assessment in oncology rehabilitation. Phys Ther. 2009;89(3):286–306.PubMedPubMedCentralCrossRef
68.
Wampler M, Miaskowski C, Hamel K, et al. The modified Total Neuropathy Score: a clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. J Support Oncol. 2006;4:397–402.
69.
Smith EM, Cohen JA, Pett MA, Beck SL. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Cancer Nurs. 2010;33(3):173–83.PubMedCrossRef
70.
Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC. Cardiotoxicity of cancer therapy. J Clin Oncol. 2005;23(30):7685–96.PubMedCrossRef
71.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166 (1):111–7.
72.
Steffen TM, Hacker TA, Mollinger L. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther. 2002;82(2):128–37.PubMed
73.
Casanova C, Cote CG, Marin JM, et al. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J. 2007;29(3):535–40.PubMedCrossRef
74.
Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54(5):743–9.PubMedCrossRef
75.
76.
Jetté M, Sidney K, Blümchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol. 1990;13(8):555–65.PubMedCrossRef
77.
78.
Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjoden PO. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer. 1991;27:1075–81.PubMedCrossRef
79.
Mock V, Dow KH, Meares CJ, et al. An exercise intervention for management of fatigue and emotional distress during radiotherapy treatment for breast cancer. Oncol Nurs Forum. 1997;24:991–1000.PubMed
80.
Evans WJ, Lambert CP. Physiological basis of fatigue. Am J Phys Med Rehabil. 2007;86(1 Suppl):S29–46.PubMedCrossRef
81.
82.
Mock V, Burke MB, Sheehan P, et al. A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 1994;21:899–907.PubMed
83.
Winograd CH. Targeting strategies: an overview of criteria and outcomes. J Am Geriatr Soc. 1991;39:25S–35S.PubMedCrossRef
84.
VanSwearingen JM, Paschal KA, Bonino P, Chen T. Assessing recurrent fall risk of community-dwelling, frail older veterans using specific tests of mobility and the Physical Performance Test of function. J Gerontol A BiolSci Med Sci. 1998;53:M457–64.CrossRef
85.
Kim EA, Mordiffi SZ, Bee WH, Devi K, Evans D. Evaluation of three fall-risk assessment tools in an acute care setting. J Adv Nurs. 2007;60(4):427–35.PubMedCrossRef
86.
Kurt G, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist. 2000;5:353–60.CrossRef
87.
Panzer VP, Wakefield DB, Hall CB, Wolfson LI. Mobility assessment: sensitivity and specificity of measurement sets in older adults. Arch Phys Med Rehabil. 2011;92(6):905–12.PubMedPubMedCentralCrossRef
88.
National Safety Council. Accidents Facts. Chicago, IL: National Safety Council, 1985.
89.
Dobson F, Hinman RS, et al. OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthr Cart. 2013;21:1042–52.CrossRef
90.
Hemenway D, Solnick SJ, Koeck C, Kytir J. The incidence of stairway injuries in Austria. Accid Anal Prev. 1994;26(5):675–9.PubMedCrossRef
91.••
Hinman MR, O’Connell JK, Dorr M, Hardin R, Tumlinson AB, Varner B. Functional predictors of stair-climbing speed in older adults. J Geriatr PhysTher. 2014;37(1):1–6. This article provides a model to assess stair climbing speed and ability.CrossRef
92.
Tan HYF, Aziz AR, Chia TKC, YHM. Reliability of the Stair-Climb Test (SCT) of cardiorespiratory fitness. Adv Exerc Sports Physiol. 2004;10(3):77–83.
93.
Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.PubMedCrossRef
94.
Nordin E, Rosendahl E, Lundin-Olsson L. Timed “up & go” test: reliability in older people dependent in activities of daily living-focus on cognitive state. Phys Ther. 2006;86(5):646–55.PubMed
95.
Thompson M, Medley A. Performance of community dwelling elderly on the timed up and go test. Phys Occup Ther Geriatr. 1995;13(3):17–30.CrossRef
96.
Nolan JS, Remilton LE, Green MM. The reliability and validity of the Elderly Mobility Scale in the acute hospital setting. Int J Allied Health Sci Pract. 2008;6(4):1–7.
97.
Yu MSW, Chan CCH, Tsim RKM. Usefulness of the Elderly Mobility Scale for classifying residential placements. Clin Rehabil. 2007;21:1114–20.PubMedCrossRef
98.
Prosser L, Canby A. Further validation of the Elderly Mobility Scale for measurement of mobility of hospitalized elderly people. Clin Rehabil. 1997;11:338–43.PubMedCrossRef
99.
Chiu AYY, Au-Yeung SSY, Lo SK. A comparison of four functional tests in discriminating fallers from non-fallers in older people. Disabil Rehabil. 2003;25:45–50.PubMedCrossRef
100.•
Rajendran V, Jeevanantham D. The Elderly Mobility Scale. J Acute Care Phys Ther. 2016;7(1):3–4. An up to date information about the tool.CrossRef
101.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94.PubMedCrossRef
102.
Bylow K, Dale W, Mustian K, et al. Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy. Urology. 2008;72(2):422–7.PubMedPubMedCentralCrossRef
103.
Volpato S, Cavalieri M, Sioulis F, Guerra G, Maraldi C, Zuliani G, Fellin R, Guralnik JM. Predictive value of the Short Physical Performance Battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci. 2011;;66(1):89–96.
104.••
Gawel J, Vengrow D, Collins J, et al. The short physical performance battery as a predictor for long term disability or institutionalization in the community dwelling population aged 65 years old or older. Phys Therapy Rev. 2012;17:37–44. Comprehensive review of the tool.CrossRef
105.
Aass N, Fossa S. Pre- and post-treatment daily life function in patients with hormone-resistant prostate carcinoma treated with radiotherapy for spinal cord compression. Radiother Oncol. 2005;74:259–65.PubMedCrossRef
106.
Yoshioka H. Rehabilitation for the terminal cancer patient. Am J Phys Med Rehabil. 1994;73:199–206.PubMedCrossRef
107.
Sabers SR, Kokal JE, Girardi JC, et al. Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment. Mayo Clin Proc. 1999;74:855–61.PubMedCrossRef
108.
Tay SS, Ng YS, Lim PA. Functional outcomes of cancer patients in an inpatient rehabilitation setting. Ann Acad Med Singapore. 2009;38(3):197–201.PubMed
109.
Cole RP, Scialla SJ, Bednarz L. Functional recovery in cancer rehabilitation. Arch Phys Med Rehabil. 2000;81(5):623–7.PubMedCrossRef
110.
Rebecca J. Timbeck, and Sandi J. Spaulding. Ability of the functional independence measure™ to predict rehabilitation outcomes after stroke: a review of the literature. 2004; 22 (1):63–76.
111.
Belani CP, Pereira JR, von Pawel J, et al. Fossella F; TAX 326 study group. Effect of chemotherapy for advanced non-small cell lung cancer on patients quality of life. A randomized controlled trial. Lung Cancer. 2006;53(2):231–9.PubMedCrossRef
112.
Bottomley A, Flechtner H, Efficace F, et al. European Organisation for Research and Treatment of Cancer (EORTC) Data Center and Quality of Life Group. Health related quality of life outcomes in cancer clinical trials. Eur J Cancer. 2005;41(12):1697–709.PubMedCrossRef
113.
Courneya KS, Friedenreich CM. Physical exercise and quality of life following cancer diagnosis: literature review. Ann Behav Med. 1999;21(2):171–9.PubMedCrossRef
114.
115.
Braun DP, Gupta D, Staren ED. Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer. 2011;15(11):353.CrossRef
116.
Shelton P, Sager MA, Schraeder C. The community assessment risk screen (CARS): identifying elderly persons at risk for hospitalization or emergency department visit. Am J Manag Care. 2000;6:925–33.PubMed
117.
Mahoney JE, Sager MA, Jalaluddin M. Use of an ambulation assistive device predicts functional decline associated with hospitalization. J Gerontol A Biol Sci Med Sci. 1999;54:M83–8.PubMedCrossRef
Metadata
Title
Assessment of physical function in geriatric oncology based on International Classification of Functioning, Disability and Health (ICF) framework
Authors
Venkadesan Rajendran
Deepa Jeevanantham
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Geriatrics Reports / Issue 3/2016
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-016-0162-0

Other articles of this Issue 3/2016

Current Geriatrics Reports 3/2016 Go to the issue

Hematology and Oncology (T Wildes, Section Editor)

Care of the Elderly Patient on Oral Oncolytics for Advanced Disease

Physical Therapy and Rehabilitation (O Addison, Section Editor)

Age-related Changes in Bilateral Upper Extremity Coordination

Hematology and Oncology (T Wildes, Section Editor)

Upper Extremity Exercise in Older Breast Cancer Survivors: Benefits of Dragon Boat Paddling

Physical Therapy and Rehabilitation (O Addison, Section Editor)

Fall Risk Among Older Adult High-Risk Populations: a Review of Current Screening and Assessment Tools

Physical Therapy and Rehabilitation (O Addison, Section Editor)

The Effects of Performance Fatigability on Postural Control and Rehabilitation in the Older Patient

Hematology and Oncology (TM Wildes, Section Editor)

Psychosocial Health of Older Adults with Cancer: Clinical Interventions Promoting Meaning and Value-Driven Behavior
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits